Description

Glyxambi is a prescription medication that combines two active ingredients, empagliflozin and linagliptin, used to improve glycemic control in adults with type 2 diabetes. It works by increasing the excretion of glucose through the urine and enhancing insulin secretion in response to meals.

Interpreter Notes

Interpreters should be aware that Glyxambi may be referred to by its components, empagliflozin and linagliptin, in some contexts. It is important to maintain the formal medical terminology and avoid colloquial terms. Ensure clarity when discussing the medication's purpose and effects to prevent confusion with other diabetes medications.

Example Sentences

EN: The doctor prescribed Glyxambi to help manage the patient's blood sugar levels.

ES: El médico recetó Glyxambi para ayudar a controlar los niveles de azúcar en sangre del paciente.

Common Interpreter Mistakes

Confusing Glyxambi with other diabetes medications; mispronouncing empagliflozin as 'empagliflozina'; using informal language when discussing the medication.